Form 10-Q · Quarterly report
Eaton Corporation 10-Q, filed Jul 31, 2026
- Filed
- CIK
- 0001551182
- Accession no.
- 0001551182-26-000030
Summary
Eaton reported second-quarter 2026 net sales of $8.531 billion, up 21% year over year, with organic growth of 14%, while net income attributable to ordinary shareholders fell 16% to $821 million and adjusted earnings rose 6% to $1.228 billion, or $3.15 per ordinary share. The company attributed the sales increase to strength in data center and machine OEM end-markets and broad-based strength in Electrical Global and Aerospace, partly offset by weakness in residential, industrial, and Mobility end-markets.
Key points
- Eaton's second-quarter 2026 net sales rose 21% to $8.531 billion, with organic growth of 14%.
- Net income attributable to Eaton ordinary shareholders fell 16% to $821 million, while adjusted earnings rose 6% to $1.228 billion.
- Diluted EPS was $2.11 versus $2.51 a year earlier, while adjusted EPS was $3.15 versus $2.95.
- Eaton recorded $154 million in second-quarter acquisition, integration, divestiture and transaction charges, and its multi-year restructuring program has incurred $397 million since inception, with total estimated charges of $475 million.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2.MANAGEMENT’S DISCUSSION RESULTS OF OPERATIONS Non-GAAP Financial Measures The following discussion of Consolidated Financial Results includes certain non-GAAP financial measures. These financial measures include adjusted earnings and adjusted earnings per ordinary share, each of which differs from the most directly comparable measure calculated in accordance with generally accepted accounting principles (GAAP). A reconciliation of adjusted earnings and adjusted earnings per ordinary share to the most directly comparable GAAP measure is included in the Consolidated Financial Results table below. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.